🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This PN-RCT replicates and evaluates an 8-week warm calling treatment (i.e....
Status
Recruiting
Location
University of Florida
Start Date
2025-09-05
Trial ID
NCT07475039
The pharmacist, as a specialist of medications, occupies a strategic positi...
Status
Completed
Location
CHU de Clermont-Ferrand
Start Date
2017-06-20
Trial ID
NCT03275675
Treatments Being Tested
This pilot study aims to test a tailored model (the I-PROTECT model) for im...
Status
Completed
Location
Eva Ageberg
Start Date
2022-03-07
Trial ID
NCT05304507
Treatments Being Tested
The purpose of this study is evaluate whether a prehabilitation program is ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2019-12-16
Trial ID
NCT04204811
Treatments Being Tested
This randomized clinical trial will test the efficacy of a Facebook interve...
Status
Completed
Location
University of California San Francisco Department of Psychiatry
Start Date
2014-10
Trial ID
NCT02207036
Treatments Being Tested
The current study proposes to use a Hybrid Type 3 implementation research s...
Status
Not Yet Recruiting
Location
Texas Christian University
Start Date
2026-07
Trial ID
NCT07528846
The goal of the Speech Accessibility Project at the University of Illinois ...
Status
Completed
Location
LSVT Global
Start Date
2023-03-15
Trial ID
NCT05889260
Halitosis is the term used to describe any unpleasant odor relative to expi...
Status
Unknown
Location
University of Nove de Julho
Start Date
2018-01-02
Trial ID
NCT03656419
Treatments Being Tested
This study will explore the effects of the Injeti Self-Love Model intervent...
Status
Completed
Location
Loma Linda University Behavioral Medicine Center
Start Date
2020-03-13
Trial ID
NCT04296812
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested